Cytokinetics Inc. (CYTK)

$ 64.60
   
  • Change Today:
    $3.34
  • 52 Week High: $68.15
  • 52 Week Low: $29.84
  • Currency: US Dollars
  • Shares Issued: 55.37m
  • Volume: 2,440,624
  • Market Cap: $3,577.10m
  • RiskGrade: 332

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest ShareCast News

CYTK ShareCast News

No recent information was found.

CYTK Newspaper Links

Amgen picks up new heart drug 28-May-2009 Chicago Tribune
Amgen pays $50 million for rights to heart drug 27-May-2009 LA Times
A Tough Quarter for Some Drug Makers 26-Jan-2007 New York Times
Amgen in deal for heart drugs 04-Jan-2007 LA Times
Amgen Acquires Option for a Heart Failure Dru 03-Jan-2007 New York Times

CYTK Tips & Analysis

Stocks end day mixed after release of Fed notes 04-Jan-2007 Wall Street Journal
Fed fears of slowdown take wind out of rally 04-Jan-2007 LA Times

CYTK News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CYTK Market Data

Currency US Dollars
Share Price $ 64.60
Change Today $ 3.34
% Change 5.45 %
52 Week High $68.15
52 Week Low $29.84
Volume 2,440,624
Shares Issued 55.37m
Market Cap $3,577.10m
RiskGrade 332

What The Brokers Say

Strong Buy 3
Buy 13
Neutral 4
Sell 0
Strong Sell 0
Total 20
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2026

Time Volume / Share Price
0 @ $0.00

Top of Page